Demographic, clinical and geographic covariates. by Shilpa Darivemula (19797310)

“…<div><p>Objective</p><p>Hospital-based labor and delivery units are closing at increasing rates in the rural US, significantly impacting maternal and newborn health. …”

<i>BRCA1</i> knockdown alleviates dysregulation of glucose and lipid metabolism in mouse primary hepatocytes. by Cui Ma (501349)

Myo10 KO-1 HeLa cells exhibit a reduction in Kizuna content at metaphase spindle poles. by Yang-In Yim (324355)

Effects of <i>BRCA1</i> overexpression on HG-induced TG and lipid metabolism in mouse hepatocytes. by Cui Ma (501349)

Characteristics of the included studies. by Fangying Chen (10321015)

“…Pooled analyses suggested that high blood eosinophils were significantly associated with increased risk of COPD exacerbation when using the thresholds of 300 cells/μL (RR 1.21, 95%CI 1.12–1.30, <i>P</i> <0.001, 16 studies), 400 cells/μL (RR 1.79, 95%CI 1.41–2.28, <i>P</i> <0.001, 3 studies), 2% (RR 1.26, 95%CI 1.02–1.55, <i>P</i> = 0.030, 10 studies) and 4% (RR 1.44, 95%CI 1.05–1.96, P = 0.022, 4 studies), but not 200 cells/μL and 3% (<i>P</i>>0.05). …”

Results of subgroup analyses. by Fangying Chen (10321015)

“…Pooled analyses suggested that high blood eosinophils were significantly associated with increased risk of COPD exacerbation when using the thresholds of 300 cells/μL (RR 1.21, 95%CI 1.12–1.30, <i>P</i> <0.001, 16 studies), 400 cells/μL (RR 1.79, 95%CI 1.41–2.28, <i>P</i> <0.001, 3 studies), 2% (RR 1.26, 95%CI 1.02–1.55, <i>P</i> = 0.030, 10 studies) and 4% (RR 1.44, 95%CI 1.05–1.96, P = 0.022, 4 studies), but not 200 cells/μL and 3% (<i>P</i>>0.05). …”

Assessment of model discrimination based on Harrell’s C-index (A) and the explained relative risk for PRS and summarized risk factors (B). by Meng Zhu (163914)

Mixed effects logistic regression (whole sample). by Eugenia Romano (11438143)

“…In SMI patients, compared to pre-incentivisation, the likelihood of being checked increased overall (ranging from OR = 1.48 <i>p</i> < .001 for blood pressure to OR = 3.70 <i>p</i> < .001 for alcohol consumption); for alcohol consumption, however, this likelihood dropped significantly to lower odds when de-incentivised compared to the pre-incentivisation period (OR = 0.83 <i>p</i> < .001). …”

S2 Data - by Sophie Biau (19864870)

“…Mixed models revealed that the Root mean square (RMS) of the tensions of the left and right reins, of the total, as well as the lunge line, were significantly influenced by rein type (p<0.001) in all cases). …”

S1 Data - by Sophie Biau (19864870)

“…Mixed models revealed that the Root mean square (RMS) of the tensions of the left and right reins, of the total, as well as the lunge line, were significantly influenced by rein type (p<0.001) in all cases). …”

Regio- and Stereoselective Synthesis of Nitro-fatty Acids as NRF2 Pathway Activators Working under Ambient or Hypoxic Conditions by Daniel Chrenko (21427903)

“…We observed that <b>9-</b> and <b>10-NO</b>_<b>2</b><b>OA</b>, and <b>10-NO</b>_<b>2</b><b>LA</b> increased NRF2 stabilization under hypoxia, while <b>9-</b> and <b>10-NO</b>_<b>2</b><b>OA</b> significantly upregulated <i>Hmox1</i> and <i>Gclm</i> at all oxygen levels. …”

Associated factors of DRPs. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Association of independent variable with DRPs. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Lifestyle-Related characteristics of patients. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Drug-Related problems identified. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Socio-Demographic characteristics of patients. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Minimal data set. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Drugs class and drugs responsible for DRPs. by Sushma Chapagain (20308080)

“…Patients were visited at their homes once identified through the community pharmacies, and a prescription review was conducted to identify the DRPs by using the Pharmaceutical Care Network Europe (PCNE) V8.02 tool and pertinent guidelines.…”

Comparison of VD and PA in the five groups of DVC. by Jin Jiang (188887)

Subjects:

Comparison of parameter indicators among groups. by Jin Jiang (188887)

Subjects: